"The next stage of our growth story has begun. In Q1 2024, we started the construction of the Centinela Second Concentrator Project, which will add a further 170,000 t/y of copper-equivalent production."
"We recently completed a 10-year mine plan that contained over 5,000 excavations, with several production schedule alternatives for economic evaluation. These detailed plans and flexibility were unimaginable thirty years agos."
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.